Trial in progress: TAGGED—A phase 2 study using low dose/metronomic trabectedin, gemcitabine, and dacarbazine as 2

Authors: Samantha Jeffrey, Jason Ballon, Anmol Dia Agarwal, Lauren Woolsey, Princess "Angela" Savage, Vanessa Xayasak, Sarosh Syed, Victoria S. Chua-Alcala, Ania M Moradkhani, Doris V. Quon, Steve Wong, Neal Shiv Chawla, Erlinda Maria Gordon, Sant P. Chawla

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps11589

Source: Full article

---

Abstract

TPS11589